← FDA DRUG APPROVALS

FDA ANDA · ANDA074745

MEGESTROL ACETATE

Sponsor: TEVA

APPLICATION
ANDA074745
TYPE
ANDA
ORIGINAL APPROVAL
1998-02-27
LATEST ACTION
2003-05-21
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

MEGESTROL ACETATEDiscontinued
MEGESTROL ACETATE 40MG · TABLET · ORAL

Approval history

2003-05-21Labeling · Supplement 5AP
2001-10-30Labeling · Supplement 4AP
2000-05-02Labeling · Supplement 3AP
1999-10-29Manufacturing (CMC) · Supplement 1AP
1999-09-23Manufacturing (CMC) · Supplement 2AP
1998-02-27OriginalReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →